Stockscreener 앱 받기
4.32
0.00%
0.00
전일 마감가:
$4.32
열려 있는:
$4.34
하루 거래량:
1,937
Relative Volume:
0.02
시가총액:
$7.94M
수익:
$9.26M
순이익/손실:
$-941.60K
주가수익비율:
-60.00
EPS:
-0.072
순현금흐름:
$-2.65M
1주 성능:
-9.81%
1개월 성능:
-15.13%
6개월 성능:
+46.94%
1년 성능:
+76.90%
1일 변동 폭
$4.34
$4.42
1주일 범위
$4.31
$4.68
52주 변동 폭
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
명칭
Bionexus Gene Lab Corp
전화
1-307-241-6898
주소
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
BGLC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
1.81 | 2.40B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.73 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.4899 | 177.85M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2341 | 505.45M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
0.998 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp 주식(BGLC)의 최신 뉴스
BioNexus Gene Lab files $100M shelf registration and establishes $20M at-the-market program - MSN
How interest rate cuts could boost BioNexus Gene Lab Corp. stock2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Will BioNexus Gene Lab Corp. stock outperform growth indexesDividend Hike & Real-Time Stock Entry Alerts - newser.com
Why BioNexus Gene Lab Corp. stock remains a top recommendation2025 Top Decliners & Proven Capital Preservation Methods - newser.com
Is BioNexus Gene Lab Corp. stock reversal real or fakeDay Trade & Breakout Confirmation Trade Signals - newser.com
Will BioNexus Gene Lab Corp. stock outperform Nasdaq indexQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
BioNexus Gene Lab Corp (BGLC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is BioNexus Gene Lab Corp. stock bottoming out2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Why BioNexus Gene Lab Corp. stock is in analyst buy zoneEarnings Beat & AI Enhanced Trading Alerts - newser.com
Chart based exit strategy for BioNexus Gene Lab Corp.July 2025 Decliners & Consistent Growth Equity Picks - newser.com
Chart overlay techniques for tracking BioNexus Gene Lab Corp.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Pattern recognition hints at BioNexus Gene Lab Corp. upsideTake Profit & Fast Entry High Yield Tips - newser.com
BioNexus Gene Lab Corp. stock chart pattern explained2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Is BioNexus Gene Lab Corp. stock a buy before product launchesWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Using portfolio simulators with BioNexus Gene Lab Corp. includedEarnings Overview Report & Capital Efficiency Focused Strategies - newser.com
What MACD signals say about BioNexus Gene Lab Corp.Quarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
BioNexus Gene Lab Corp SEC 10-Q Report - TradingView
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
What to do if you’re stuck in BioNexus Gene Lab Corp.Weekly Market Outlook & Expert Verified Stock Movement Alerts - newser.com
Is BioNexus Gene Lab Corp. stock a smart buy before Fed meeting2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Fundação Cultural do Pará
Check Out BioNexus Gene Lab Corp (BGLC)’s Trade Data Rather Than the Analysts’ Views - setenews.com
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization - BioSpace
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform By Investing.com - Investing.com Nigeria
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic - GlobeNewswire
BioNexus Gene Lab Corp. Announces Strategic Agreements with Fidelion Diagnostics Pte. Ltd. and Tongshu Biotechnology (Hong Kong) Co., Limited for Southeast Asia MRD Commercialization - MarketScreener
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention? - Asianet Newsable
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform - Investing.com India
BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Philippines
Bionexus Gene Lab Corp (BGLC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.25%
자본화:
|
볼륨(24시간):